Can you explain to me why you would have MSB ramp up production when there is no guarantee a product will be approved by FDA?
Why should MSB take the risk? If more die, it is on FDA's head for not approving use in aGVHD (despite 9 to 1 experts wanting it approved).
- Forums
- ASX - By Stock
- MSB
- Ann: Remestemcel-L FDA Fast Track Designation for COVID-19 ARDS
Ann: Remestemcel-L FDA Fast Track Designation for COVID-19 ARDS, page-430
-
- There are more pages in this discussion • 143 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.09 |
Change
0.028(2.59%) |
Mkt cap ! $1.218B |
Open | High | Low | Value | Volume |
$1.08 | $1.10 | $1.06 | $1.834M | 1.701M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
13 | 20309 | $1.09 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.09 | 36377 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 30220 | 1.080 |
19 | 61775 | 1.075 |
11 | 49838 | 1.070 |
11 | 80046 | 1.065 |
14 | 112206 | 1.060 |
Price($) | Vol. | No. |
---|---|---|
1.085 | 107061 | 7 |
1.090 | 54363 | 7 |
1.095 | 192198 | 14 |
1.100 | 150314 | 22 |
1.105 | 34250 | 4 |
Last trade - 13.09pm 03/09/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |